home All News open_in_new Full Article

Dogwood Therapeutics, Inc. Announces Conversion of Existing $19.5M in Debt to Equity, Strengthening Balance Sheet Moving Forward

Largest shareholder, CK Life Sciences Int’l., (Holdings) Inc. agrees to conversion of debt into equity, removing all existing debt from Dogwood’s balance sheet ATLANTA, March 12, 2025 (GLOBE NEWSWIRE) — Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a development-stage biopharmaceutical company focused on advancing first-in-class, non-opioid, treatments for chronic and acute pain, announces […]



Dogwood Therapeutics (Nasdaq: DWTX) announced that CK Life Sciences Int'l., (Holdings) Inc., its largest shareholder, agreed to convert $19.5 million in debt to equity in exchange for preferred equity, removing all existing debt from Dogwood's balance sheet. This is expected to strengthen Dogwood's balance sheet and make it a more attractive investment opportunity. The conversion ensures sufficient capital for the Halneuron Phase 2b chemotherapy-induced neuropathic pain trial.

today 48 h. ago attach_file Economics

attach_file Other
attach_file Economics
attach_file Economics
attach_file Other
attach_file Economics
attach_file Economics
attach_file Economics


ID: 81684614
Add Watch Country

arrow_drop_down